These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36463161)

  • 1. Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.
    Ait Hamou Z; Levy N; Charpentier J; Mira JP; Jamme M; Jozwiak M
    Respir Res; 2022 Dec; 23(1):329. PubMed ID: 36463161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of modified ROX index in predicting the outcome of patients with acute respiratory distress syndrome due to SARS-CoV-2 infection treated with high-flow nasal cannula oxygen therapy].
    Wang X; Zhang Z; Cao W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):585-590. PubMed ID: 38991956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the successful application of high-flow nasal oxygen cannula in patients with COVID-19 respiratory failure: a retrospective analysis.
    Yu PT; Chen CH; Wang CJ; Kuo KC; Wu JC; Chung HP; Chen YT; Tang YH; Chang WK; Lin CY; Wu CL
    Expert Rev Respir Med; 2023 Apr; 17(4):319-328. PubMed ID: 37002880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.
    Kwon H; Ha SW; Kim B; Chae B; Kim SM; Hong SI; Kim JS; Kim YJ; Ryoo SM; Kim WY
    Am J Emerg Med; 2024 Jan; 75():53-58. PubMed ID: 37913715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].
    Liu T; Zhao Q; Shi Z; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):686-691. PubMed ID: 34296687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study.
    Kim JH; Baek AR; Lee SI; Kim WY; Na YS; Lee BY; Seong GM; Baek MS
    PLoS One; 2022; 17(5):e0268431. PubMed ID: 35551328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study.
    Poopipatpab S; Nuchpramool P; Phairatwet P; Lertwattanachai T; Trongtrakul K
    PLoS One; 2023; 18(6):e0287432. PubMed ID: 37343046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia.
    Su L; Zhao Q; Liu T; Xu Y; Li W; Zhang A
    Lung; 2021 Oct; 199(5):447-456. PubMed ID: 34448939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.
    Hirabayashi R; Nagata K; Sato Y; Nakagawa A; Tachikawa R; Kuroda H; Seo R; Morimoto T; Tomii K
    BMC Pulm Med; 2023 Aug; 23(1):294. PubMed ID: 37559018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Respiratory Rate Oxygenation Index: An Early Warning Index for the Need of Intubation in COVID-19 Patients with High-Flow Nasal Cannula Therapy.
    Ai T; Zhang Z; Tan Z; Shi Z; Li H; Zhang S; Zhao X; Yao Y; Li W; Gao Y; Zhu M
    J Emerg Med; 2023 Aug; 65(2):e93-e100. PubMed ID: 37479639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors.
    Raboni SM; Neves VC; Silva RM; Breda GL; Ceregato AC; Broza TP; de Oliveira G; Melo-Diaz LL; Braga CB; Carraro CF; Arroyo NC; Bardy RF; Devetak GF; Ozawa CM; Graf ME; Dias VL; Ducroquet MA; Nunes DP; Sokoloski CS; Petterle RR
    Respir Care; 2022 Nov; 67(11):1443-1451. PubMed ID: 35944966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study.
    Alshahrani MS; Alshaqaq HM; Alhumaid J; Binammar AA; AlSalem KH; Alghamdi A; Abdulhady A; Yehia M; AlSulaibikh A; Al Jumaan M; Albuli WH; Ibrahim T; Yousef AA; Almubarak Y; Alhazzani W
    Saudi J Med Med Sci; 2021; 9(3):215-222. PubMed ID: 34667467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of risk factors for the failure of respiratory support with high-flow nasal cannula oxygen therapy in children with acute respiratory dysfunction: A case-control study.
    Liu J; Li D; Luo L; Liu Z; Li X; Qiao L
    Front Pediatr; 2022; 10():979944. PubMed ID: 36081624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the failure of High Flow Nasal Cannula Oxygen therapy in Intensive Care follow-up of COVID-19 Severe Respiratory Failure.
    Fulya Ç; Ersin K; Mehmet G; Yeliz B; Elif B; Kemal S
    Malawi Med J; 2022 Mar; 34(1):37-42. PubMed ID: 37265829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
    Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J
    Ther Adv Respir Dis; 2022; 16():17534666221091931. PubMed ID: 35467449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?
    Delbove A; Foubert A; Mateos F; Guy T; Gousseff M
    Ther Adv Respir Dis; 2021; 15():17534666211019555. PubMed ID: 34057844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.
    Basoulis D; Avramopoulos P; Aggelara M; Karamanakos G; Voutsinas PM; Karapanou A; Psichogiou M; Samarkos M; Ntziora F; Sipsas NV
    Can Respir J; 2023; 2023():7474564. PubMed ID: 36817550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation.
    Saillard C; Lambert J; Tramier M; Chow-Chine L; Bisbal M; Servan L; Gonzalez F; de Guibert JM; Faucher M; Sannini A; Mokart D
    PLoS One; 2022; 17(6):e0270138. PubMed ID: 35767521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study.
    Sudo K; Sawa T; Kushimoto K; Yoshii R; Yuasa K; Inoue K; Kinoshita M; Yamasaki M; Kooguchi K
    PeerJ; 2023; 11():e15174. PubMed ID: 37065694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.